These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9383374)

  • 1. Falling out of the fold: tumorigenic mutations and p53.
    Erlanson DA; Verdine GL
    Chem Biol; 1994 Oct; 1(2):79-84. PubMed ID: 9383374
    [No Abstract]   [Full Text] [Related]  

  • 2. Folding of tetrameric p53: oligomerization and tumorigenic mutations induce misfolding and loss of function.
    Lubin DJ; Butler JS; Loh SN
    J Mol Biol; 2010 Jan; 395(4):705-16. PubMed ID: 19913028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in the P53 tumour suppressor gene in primary lung cancer in Japan.
    Kondo K; Umemoto A; Akimoto S; Uyama T; Hayashi K; Ohnishi Y; Monden Y
    Biochem Biophys Res Commun; 1992 Mar; 183(3):1139-46. PubMed ID: 1348931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations of the p53 tumour suppressor gene in haematologic neoplasms.
    Mori N; Wada M; Yokota J; Terada M; Okada M; Teramura M; Masuda M; Hoshino S; Motoji T; Oshimi K
    Br J Haematol; 1992 Jun; 81(2):235-40. PubMed ID: 1643020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in the p53 tumor suppressor gene in tree shrew hepatocellular carcinoma associated with hepatitis B virus infection and intake of aflatoxin B1.
    Park US; Su JJ; Ban KC; Qin L; Lee EH; Lee YI
    Gene; 2000 Jun; 251(1):73-80. PubMed ID: 10863098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor suppressor genes: at the crossroads of molecular carcinogenesis, molecular epidemiology, and human risk assessment.
    Harris CC
    Prev Med; 1996; 25(1):10-2. PubMed ID: 8778751
    [No Abstract]   [Full Text] [Related]  

  • 7. Mutational spectra and immunohistochemical analyses of p53 in human cancers.
    Bennett WP; Hollstein MC; Hsu IC; Sidransky D; Lane DP; Vogelstein B; Harris CC
    Chest; 1992 Mar; 101(3 Suppl):19S-20S. PubMed ID: 1541189
    [No Abstract]   [Full Text] [Related]  

  • 8. [Frequent point mutations in the p53 tumor suppressor gene in human vulvar cancer].
    Speiser P; Schmid W; Czervenka K; Peschke M; Zeillinger R; Kubista E
    Gynakol Geburtshilfliche Rundsch; 1992; 32 Suppl 1():31-2. PubMed ID: 1337493
    [No Abstract]   [Full Text] [Related]  

  • 9. Benzo[a]pyrene-induced murine skin tumors exhibit frequent and characteristic G to T mutations in the p53 gene.
    Ruggeri B; DiRado M; Zhang SY; Bauer B; Goodrow T; Klein-Szanto AJ
    Proc Natl Acad Sci U S A; 1993 Feb; 90(3):1013-7. PubMed ID: 8430068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 mutations: gains or losses?
    Michalovitz D; Halevy O; Oren M
    J Cell Biochem; 1991 Jan; 45(1):22-9. PubMed ID: 2005181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical implications of the p53 tumor-suppressor gene.
    Harris CC; Hollstein M
    N Engl J Med; 1993 Oct; 329(18):1318-27. PubMed ID: 8413413
    [No Abstract]   [Full Text] [Related]  

  • 12. [P53 and cancers].
    May P; May E
    Pathol Biol (Paris); 1995 Mar; 43(3):165-73. PubMed ID: 7675543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promotability and tissue specificity of hereditary cancer genes: do hereditary cancer patients have a reduced requirement for tumor promotion because all their somatic cells are heterozygous at the predisposing locus?
    Paraskeva C; Williams AC
    Mol Carcinog; 1992; 5(1):4-8. PubMed ID: 1543540
    [No Abstract]   [Full Text] [Related]  

  • 14. [Recent discoveries of cancer genes: what are the consequences for public health?].
    Bonaïti-Pellié C
    Rev Epidemiol Sante Publique; 1995; 43(2):105-6. PubMed ID: 7732196
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification of a germ-line mutation in the p53 gene in a patient with an intracranial ependymoma.
    Metzger AK; Sheffield VC; Duyk G; Daneshvar L; Edwards MS; Cogen PH
    Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7825-9. PubMed ID: 1679237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tumor suppressor gene p53--function and significance in gastroenterology].
    Schoppmeyer K; Keim V; Mössner J
    Z Gastroenterol; 1997 Jun; 35(6):491-509. PubMed ID: 9281241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor suppressor genes and cancer of the human nervous system.
    Chung RY; Seizinger BR
    Cancer Invest; 1991; 9(4):429-37. PubMed ID: 1884250
    [No Abstract]   [Full Text] [Related]  

  • 18. Oncogenes and antioncogenes in the development of HPV associated tumors.
    Crawford L; Tommasino M
    Clin Dermatol; 1997; 15(2):207-15. PubMed ID: 9167905
    [No Abstract]   [Full Text] [Related]  

  • 19. The properties of p53 proteins selected for the loss of suppression of transformation.
    Olson DC; Levine AJ
    Cell Growth Differ; 1994 Jan; 5(1):61-71. PubMed ID: 8123594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure of the p53 tumor suppressor bound to the ankyrin and SH3 domains of 53BP2.
    Gorina S; Pavletich NP
    Science; 1996 Nov; 274(5289):1001-5. PubMed ID: 8875926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.